Welcome to our two new experts!
Antwerp, March 1st, 2021:
S-Biomedic, a pioneering skin microbiome company is accelerating its commercialization efforts and broadening its development pipeline for cosmetics and dermatology.
To this end, S-Biomedic decided to strengthen both its marketing and research teams and is pleased to announce and welcome two new collaborators: Lisa Beckermann as Junior Formulation Scientist and Kanto Razafindrazaka as Junior Product Manager!
After working at L’Oreal, Lisa joins S-Biomedic to collaborate closely with the Scientific and Marketing Department strengthening the cosmetic formulation know-how the company.
As for Kanto, prior to joining the team, she worked at a premium cosmetics brand where she was in charge of the digital marketing. Today, Kanto brings her expertise in customer communication and content development.
“The whole team is very excited for Lisa and Kanto to join and to bring their energy and experience. I wish both a lot of success and look very much forward to working together!” shares Veronika Oudova, the CEO of S-Biomedic.
With their passion for cosmetics, there is no doubt that Lisa and Kanto will accelerate the pioneering activities of S-Biomedic.
”We were excited by the rare combination of a formidable team, a compelling technology and strategic collaboration with industry giants”, says Investment Manager Michael Blank, explaining investiere.ch’s motivation to join this Series A. “In our opinion, S-Biomedic has all the ingredients to blaze a new trail in the skin microbiome field.”
About S-Biomedic
S-Biomedic is a Belgium-based life-science company working with live bacteria to develop treatments and products for skin disorders. S-Biomedic has developed a method to directly modulate the skin microbiome, with applications in dermatology and the cosmetic industry.
The skin microbiome, a habitat of billions of good and bad bacteria, contributes to clinical conditions ranging from acne, eczema and rosacea, to ageing. Currently, S-Biomedic has developed its first active ingredient targeting acne and is further expanding its range of additional cosmetic and therapeutic applications to include solutions for skin ageing and dandruff. More information on www.sbiomedic.com.
For more information please contact:
S-Biomedic
Veronika Oudova, CEO
Veronika.oudova@sbiomedic.com
Phone +32 477269940
Download the press release below.